Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Insmed Incorporated - Common Stock (NQ:INSM)

73.62 +0.88 (+1.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insmed Incorporated - Common Stock

< Previous 1 2 3 4 5 Next >
Insmed Is Making A Comeback — Why Shares Hit A Year High In Colossal Volume
The company is working on a treatment for a bacterial lung infection. 
Via Investor's Business Daily
Why Lung Disease Focused Stock Insmed Is Trading Higher Today?
Insmed Incorporated (NASDAQ: INSM) shares are trading higher after the company released topline results from its Phase 3 ARISE study of ARIKAYCE in patients with newly diagnosed or recurrent... 
Via Benzinga
Why Insmed Stock Is Soaring Today
Investors applauded the company's latest clinical results. 
Via The Motley Fool
Brady, Airbnb, Insmed And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 100 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2023
Via Benzinga
Insmed: Q1 Earnings Insights
Via Benzinga
Insmed's Return On Capital Employed Insights
Via Benzinga
A Preview Of Insmed's Earnings
Via Benzinga
Analysts and Executives Converge February 2nd at the 30th Annual Emerald Groundhog Day Investment Forum
From Emerald Asset Management PA, LLC
Via Business Wire
Barclays Maintains Overweight Rating for Insmed: Here's What You Need To Know
Via Benzinga
Analyst Expectations for Insmed's Future
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Analyst Ratings for Insmed
Via Benzinga
What 4 Analyst Ratings Have To Say About Insmed
Via Benzinga
Why Insmed's Shares Fell 14.7% on Wednesday
The biotech company is raising money to help it launch another drug, but it's diluting current shareholders in the process. 
Via The Motley Fool
Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving Premarket
Gainers 
Via Benzinga
Coupa Software, Horizon Therapeutics And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
Upgrades 
Via Benzinga
Insmed's Return On Capital Employed Insights
  
Via Benzinga
Insmed's Return On Capital Employed Overview
Benzinga Pro data, Insmed (NASDAQ:INSM) reported Q3 sales of $67.73 million. Earnings fell to a loss of $131.15 million, resulting in a 37.12% decrease from last quarter. 
Via Benzinga
$1.4 Million Bet On This Real Estate Stock? 3 Stocks Insiders Are Buying
Although US stocks closed lower on Wednesday, there were a few notable insider trades. 
Via Benzinga
Insmed: Q3 Earnings Insights
Insmed (NASDAQ:INSM) reported its Q3 earnings results on Thursday, October 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Insmed missed estimated earnings by... 
Via Benzinga
iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday
U.S. stocks closed mixed on Friday following the release of jobs data for July. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
Gainers Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of... 
Via Benzinga
Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session
Gainers SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share... 
Via Benzinga
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday. 
Via Benzinga
Insmed's Return On Capital Employed Overview
According to data from Benzinga Pro, during Q1, Insmed's (NASDAQ:INSM) reported sales totaled $53.11 million. Despite a 16.25% increase in earnings, the company posted a loss of $94.62 million. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.